MetaCap

Claritev (CTEV) vs Phreesia (PHR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Claritev (CTEV) has outperformed Phreesia (PHR) over the past year, losing 55.0% versus a loss of 55.1%. Over five years, PHR leads with a -83.5% price change compared with -86.5% for CTEV. Phreesia is the larger company by market cap ($651.7 million vs $424.2 million), about 1.5 times the size.

On valuation, Claritev trades at a lower forward P/E (3.4x vs 6.6x for Phreesia).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTEV-55.01%PHR-55.15%
+33%-24%-81%
Oct 7, 20251 yearOct 7, 2026
CTEV-87.61%PHR-82.72%
+27%-38%-103%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTEV versus PHR key metrics
MetricCTEVPHR
Share price$25.03$10.50
Market cap$424.20M$651.74M
1-day change+3.90%+2.44%
YTD return-41.45%-37.94%
1-year return-55.01%-55.15%
5-year return-86.51%-83.51%
P/E ratio (TTM)—61.76
Forward P/E3.416.64
EPS (TTM)$-17.66$0.17
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$73.68$24.25
52-week low$11.50$7.77
Distance from 52-week high-66.03%-56.69%
Analyst consensusbuybuy
Avg. price target upside+83.78%+34.00%
Average volume133.69K743.85K
Shares outstanding16.95M62.07M
Employees3,0001,789
SectorHealthcareHealthcare
IndustryHealth Information ServicesHealth Information Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Claritev

CTEV stock →

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.

Healthcare · Health Information Services · 3,000 employees

About Phreesia

PHR stock →

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

Healthcare · Health Information Services · 1,789 employees

CTEV vs PHR FAQ

Which is bigger, Claritev or Phreesia?

Phreesia (PHR) is larger, with a market capitalization of $651.74M compared with $424.20M for Claritev (CTEV).

Which stock has performed better over the past year, CTEV or PHR?

CTEV returned -55.01% over the past 12 months, compared with -55.15% for PHR (price return, excluding dividends). Past performance does not predict future results.

Are Claritev and Phreesia in the same industry?

Yes. Both are classified in the Health Information Services industry within the Healthcare sector.

More comparisons